Atlas Trials

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

Clinical trial NCT05672355 · SUSPENDED

Trial details

NCT number
NCT05672355
Sponsor
City of Hope Medical Center
Status
SUSPENDED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaCOVID-19 Infection
Start date
2023-08-01
Primary completion
2029-01-12
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.